Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000318306-06-000019
Filing Date
2006-08-23
Accepted
2006-08-23 15:15:28
Documents
5
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q/A r10q-695.txt 10-Q/A 115131
2 CEO CERTIFICATION r10q-696.txt EX-31.1 3628
3 CFO CERTIFICATION r10q-697.txt EX-31.2 3623
4 CEO CERTIFICATION r10q-698.txt EX-32.1 1846
5 CFO CERTIFICATION r10q-699.txt EX-32.2 1845
  Complete submission text file 0000318306-06-000019.txt   127777
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-15771 | Film No.: 061050832
SIC: 2834 Pharmaceutical Preparations